Zobrazeno 1 - 10
of 14
pro vyhledávání: '"C A, Cull"'
Autor:
C. A. Cull, S. W. Brown
Publikováno v:
Behavioural Neurology, Vol 5, Iss 1, Pp 47-51 (1992)
In this paper, reasons for the occurrence of interictal behaviour disturbance in children with epilepsy, and the management of such problems, are considered. The search for a direct relationship between epilepsy related variables and behaviour disord
Externí odkaz:
https://doaj.org/article/01c2c1b8ffea4fb39dc2049ce3c60bd8
Publikováno v:
Journal of animal science. 93(6)
The objective of this study was to quantify cattle performance and carcass characteristics associated with administration of a siderophore receptor and porin proteins-based vaccine (VAC) and a direct-fed microbial (DFM), which were originally evaluat
Autor:
Ian R. Mackay, Rury R. Holman, Timothy M. E. Davis, Merrill J. Rowley, Z Mehta, C A Cull, David G. Bruce, Shahnaz Fida
Publikováno v:
Diabetic Medicine. 20:198-204
Aims The autoantigen SOX-13 of the SRY-related high mobility group box is a low-frequency reactant in sera from patients with Type 1 diabetes. We further investigated the potential diagnostic role of anti-SOX-13, and in particular its ability to dist
Autor:
C A, Cull, S W, Brown
Publikováno v:
Behavioural neurology. 5(1)
In this paper, reasons for the occurrence of interictal behaviour disturbance in children with epilepsy, and the management of such problems, are considered. The search for a direct relationship between epilepsy related variables and behaviour disord
Publikováno v:
Journal of veterinary pharmacology and therapeutics. 35(4)
The pharmacokinetics of oral meloxicam has been studied in ruminant, but not preruminant calves. Oral meloxicam was administered at 0.5 mg/kg to six ruminant calves via gavage (RG); to six preruminant calves via gavage (PRG); and to six preruminant c
Autor:
M E Nanson, J E Tooke, Hadden, R J Seaman, Peacock Ida., C Roxburgh, R J Young, S Aldington, C Battersby, Hayes, C J Fox, P A Bassett, L Kennedy, Neil Haw., J Singer, R B Paisey, M H Charlton, N A Levi, L J Borthwick, M Badenoch, S F Oakes, R W Henry, C Hagan, J S Yudkin, A B Atkinson, N Keen, R C Turner, M J Williams, M S Hammersley, R S Spivey, S L Franklin, E M Kohner, Ae Fletcher, R T Jung, B Kilgallan, S E Manley, C A Cull, Clyne, E M Sellen, Lean Mej., R H Greenwood, Brunt Ahe., Boulton Ajm., M S Fetherston, V Frighi, P M Brown, Matthews, R Coster, A S Spathis, Richard Peto, A D Wright, J M Roland, A J Tucker, Shearer Aci., J M Tyrell, Petrie Xmp., Rury R. Holman, M C Holloway, R A Christie, R W Newton, H M Coghill, Culverwell Njc., T L Dornan, L E Murchison, S L Palmer, M C Doddridge, A M Robertson, R C Temple, L M James, Thompson Rjw., I Ross, I M Stratton, M R Stearn, C Gould, E A Eeley, Brown Npr., C Rose, A C Burden, J Youens, D W Macpearson, J Wilson, M J Denholm, D J Brown, I A Kennedy, D J Wheatcroft, Hockaday Tdr., Connolly Bps., A M Culbert, Davidson Ajm., E G Bown
Publikováno v:
Journal of Hypertension. 11:309-317
Objective: To determine the prevalence of hypertension in newly diagnosed type 2 diabetic patients and its association with risk factors for cardiovascular and diabetic complications.Design: Cross-sectional study.Patients: Newly diagnosed type 2 diab
Publikováno v:
Diabetes care. 24(7)
To assess the relationship among self-reported ethnicity, metabolic control, and blood pressure during treatment of type 2 diabetes.We studied 2,999 newly diagnosed type 2 diabetic patients recruited to the U.K. Prospective Diabetes Study who were ra
Autor:
S E, Manley, I M, Stratton, C A, Cull, V, Frighi, E A, Eeley, D R, Matthews, R R, Holman, R C, Turner, H A, Neil
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 17(7)
To assess the effect of diet on fasting plasma lipids and lipoproteins in patients with newly diagnosed Type 2 diabetes.A total of 2,906 patients each underwent 3 months' diet therapy before allocation to therapy in a randomized controlled clinical t
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 15(4)
Patients with Type 2 (non-insulin-dependent) diabetes mellitus (DM) on sulphonylurea therapy convert to insulin progressively as the sulphonylureas 'fail'. The rate of failure and the features of those who fail have been poorly described. To assess s
Publikováno v:
Diabetes care. 19(2)